Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/22/2003US20030096963 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096962 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell prolifefrative and tumor disorders
05/22/2003US20030096961 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096960 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096959 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096958 Polypeptide for use in the treatment of cancer and kidney disorders
05/22/2003US20030096957 AFX (zeta) transcription factor splice form
05/22/2003US20030096956 Process for producing kiss-1 peptide
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
05/22/2003US20030096952 Novel proteins and nucleic acids encoding same
05/22/2003US20030096951 Polypeptide for use in the diagnosis and treatment of nervous sytem disorders
05/22/2003US20030096950 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
05/22/2003US20030096949 Microbiocidal peptide for use in the treatment of respiratory system disorders
05/22/2003US20030096947 Placental organic anion transporter and gene thereof
05/22/2003US20030096787 Comprising the ITR sequences, a sequence permitting the encapsulation, a heterologous DNA sequence, and in which the E1 gene and at least one of the E2, E4 and L1-L5 genes is non-functional
05/22/2003US20030096785 Antisense agents to nucleic acids encoding human proteins (G protein-coupled receptors designated GPR12 and GPR3), which are expressed in the hypothalamus, to suppress hunger; antibodies, drug screening
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096781 Interleukin-8 (IL-8); antisense nucleotide targeted to IL-8 for rapid treatment without the associated cumulative toxicity of conventional treatments
05/22/2003US20030096780 High affinity IP3-binding polypeptide
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096778 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
05/22/2003US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes
05/22/2003US20030096767 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed
05/22/2003US20030096757 Matrix metalloproteinases inhibitor peptides having sequences related to cleavage regions of the proenzyme forms of matrix
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096754 Vascular endothelial growth factor variants
05/22/2003US20030096753 Therapeutic agent
05/22/2003US20030096752 Net charge of -3-3 at pH 7 and with the amino acids arginine15 or arginine15-alanine17 in the binding region; serine protease inhibitors
05/22/2003US20030096751 G-protein coupled receptor polynucleotides and methods of use thereof
05/22/2003US20030096750 Recombinant DNA of a gene having a DNA sequence or amino acid sequence; antitumor agents
05/22/2003US20030096749 Human cytokine receptor
05/22/2003US20030096746 Compounds and methods for inhibiting cancer metastasis
05/22/2003US20030096745 A conjugated cecropins and magainins with one or more replaced peptides; bactericides, fungicides and anticarcinogenic agent; nontoxic
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096741 Enhanced mineral delivery
05/22/2003US20030096739 Nuclear receptor-mediated introduction of a PNA into cell nuclei
05/22/2003US20030096732 Regulating gene expression of telomerase reverse transcriptase (TERT); therapeutic agent screening applications
05/22/2003US20030096431 Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/22/2003US20030096417 Vaccination against feline immunodeficiency virus
05/22/2003US20030096416 Gene which exhibits induced expression by stress
05/22/2003US20030096415 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
05/22/2003US20030096402 Chemically defined medium for cultured mammalian cells
05/22/2003US20030096400 N-terminally chemically modified protein compositions and methods
05/22/2003US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/22/2003US20030096388 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096376 Generation of autoinducer-2; obtain S-adenosylhomocysteine, incubate with preferential protein, allow conversion of s-adenosylhomocysteine to autoinducer-2
05/22/2003US20030096373 Antibody for use in the detection of tumors
05/22/2003US20030096371 Human cytokines
05/22/2003US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096367 Protein for use in the treatment of cell proliferative, autoimmune and nervous system disorders
05/22/2003US20030096365 Biochemical and genetic characterization of propionicin T1
05/22/2003US20030096364 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096360 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel alpha-subunit
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease
05/22/2003US20030096355 Nuclleotide sequences coding polypeptide for use in the treatment of cachexia, toxic shock syndrome, inflammation, rheumatoid and osteoarthritis
05/22/2003US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders
05/22/2003US20030096353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease
05/22/2003US20030096351 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096348 DNA molecules encoding mammalian nuclear receptor protein, nNR5
05/22/2003US20030096347 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof
05/22/2003US20030096346 Nucleic acids, proteins, and antibodies
05/22/2003US20030096345 15569, a novel human G protein coupled receptor and uses therefor
05/22/2003US20030096343 Modular assembly of antibody genes, antibodies prepared thereby and use
05/22/2003US20030096340 Nucleotide sequences coding polypeptide for use in the treatment, diagnosi and prevention of skin, kidney and cell proliferative disorders
05/22/2003US20030096339 Nucleotide sequence coding polypeptide for use in the treatment cell proliferative disorders
05/22/2003US20030096338 Protein conjugate for use in the treatment of blood disorder
05/22/2003US20030096337 Polynucleotides encoding a human S100 protein
05/22/2003US20030096336 Insect sodium channels from insecticide-susceptible and insecticide-resistant house flies
05/22/2003US20030096330 Genetically engineered cell for use as tool in controlling bacterial propagation and infection
05/22/2003US20030096329 (1-3)-beta-D-glucan binding domain protein, measuring method using the substance and assay kit
05/22/2003US20030096326 Gene product over expressed in cancer cells
05/22/2003US20030096320 Oil bodies and associated proteins as affinity matrices
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096305 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of brain, viral and respiratory disorders
05/22/2003US20030096304 Nuclear matrix protein fluid assay
05/22/2003US20030096300 Nucleotide sequences coding polypeptide for use in the treatment of brain, gastrointestinal, respiratory and reproductive disorders
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
05/22/2003US20030096288 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
05/22/2003US20030096282 Gtpase-activating protein 1
05/22/2003US20030096279 Nuccleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/22/2003US20030096272 Genes regulated by peroxisome proliferator-activated receptor gamma agonist
05/22/2003US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
05/22/2003US20030096267 Essential bacterial genes and their use
05/22/2003US20030096260 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
05/22/2003US20030096259 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
1 ... 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 ... 2916